{"database": "lobbying", "table": "lobbying_activities", "rows": [[1991383, "f26ce0f8-49f7-42fb-8da2-e4e3ed9d466b", "Q2", "TARPLIN, DOWNS & YOUNG, LLC", 304736, "ABBVIE INC.", 2017, "second_quarter", "MMM", "discount programs, hepatitis C, Sunshine, pipeline, biosimilars, Part B demonstration, Part D, Noninterference\n\nS. 251 - Protecting Medicare from Executive Action of 2017\nS. 260/H.R. 849 - Protecting Seniors' Access to Medicare Act of 2017\nH.J.Res. 51/S.J.Res. 16 - IPAB discontinuation\nS. 41 - Medicare Prescription Drug Price Negotiation Act of 2017", "Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE", 60000, null, 0, 0, "2017-07-18T12:15:48.970000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1991383"], "units": {}, "query_ms": 0.33414410427212715, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}